Heart Test Laboratories
HSCS
7 hedge funds and large institutions have $53.4K invested in Heart Test Laboratories in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 19 closing their positions.
1.53% more ownership
Funds ownership: 0.02% → 1.55% (+1.5%)
68% less funds holding
Funds holding: 22 → 7 (-15)
71% less capital invested
Capital invested by funds: $181K → $53.4K (-$128K)
79% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 19
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$50.8K |
| 2 |
Morgan Stanley
New York
|
+$18.2K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$32 |
| 4 |
JP Morgan Chase
New York
|
+$8 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$22.4K |
| 2 |
TWM
Tradition Wealth Management
Edina,
Minnesota
|
-$21.1K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$19.3K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$14.4K |
| 5 |
HF
HRT Financial
New York
|
-$14K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Wells Fargo
San Francisco,
California
| – | -$53 | -5 | Closed |
|
HSCS Hedge Fund Activity: Q2 2024 in Review
7 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Heart Test Laboratories (HSCS) for Q2 2024, worth a combined $53.4K — down 71% from $181K a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of HSCS and 4 opened new positions — a net loss of 15 holders — while 2 trimmed existing stakes and 0 added.
The largest buyer was UBS Group, opening a new position worth an estimated $50.8K. The largest seller was Vanguard Group, exiting entirely with an estimated $22.4K sold.
- 7 institutional investors held Heart Test Laboratories (HSCS) as of Q2 2024, down from 22 in Q1 2024.
- Funds reported $53.4K of Heart Test Laboratories stock for Q2 2024, down 71% quarter-over-quarter.
- 4 funds opened new Heart Test Laboratories positions in Q2 2024 and 19 closed out, a net change of -15 holders.
- The largest Heart Test Laboratories buyer in Q2 2024 was UBS Group, an estimated $50.8K added.
- The largest Heart Test Laboratories seller in Q2 2024 was Vanguard Group, an estimated $22.4K sold.
Based on aggregated 13F filings for Q2 2024.